{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:02:40Z","timestamp":1789614160527,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.breast.2026.104895","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:04:15Z","timestamp":1786464255000},"page":"104895","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Local treatment for HER2-positive or triple negative second ipsilateral breast cancer event: A propensity score-matched analysis of the GEC-ESTRO database"],"prefix":"10.1016","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8177-3245","authenticated-orcid":false,"given":"J.M.","family":"Hannoun-Levi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1802-118X","authenticated-orcid":false,"given":"J.","family":"Gal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7790-7151","authenticated-orcid":false,"given":"C.","family":"Weltens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9120-7829","authenticated-orcid":false,"given":"V.","family":"Smanyko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8749-2501","authenticated-orcid":false,"given":"D.","family":"Kauer-Domer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Pasquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lemanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Racadot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Houvenaeghel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0481-5923","authenticated-orcid":false,"given":"B.","family":"Guix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Belliere-Calandry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Loessl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Polat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Galalae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Polgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5104-9507","authenticated-orcid":false,"given":"R.","family":"Schiappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3871-7563","authenticated-orcid":false,"given":"V.","family":"Strnad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.breast.2026.104895_bib2","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.breast.2026.104895_bib3","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat Med"},{"issue":"10237","key":"10.1016\/j.breast.2026.104895_bib4","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.breast.2026.104895_bib5","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S1470-2045(25)00194-9","article-title":"Partial-breast radiotherapy after breast conservation surgery for women with early breast cancer (UK IMPORT LOW): 10-year outcomes from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial","volume":"26","author":"Kirby","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2026.104895_bib6","article-title":"Development and validation of an ipsilateral breast tumor recurrence risk estimation tool incorporating real-world data and evidence from meta-analyses: a retrospective multicenter cohort study","volume":"9","author":"Sagara","year":"2025","journal-title":"JCO Clin Cancer Inform"},{"issue":"2","key":"10.1016\/j.breast.2026.104895_bib7","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ijrobp.2020.12.029","article-title":"Salvage mastectomy versus second conservative treatment for second ipsilateral breast tumor event: a propensity score-matched cohort analysis of the GEC-ESTRO breast cancer working group database","volume":"110","author":"Hannoun-Levi","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.breast.2026.104895_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/jamaoncol.2019.4320","article-title":"Effectiveness of breast-conserving surgery and 3-Dimensional conformal partial breast reirradiation for recurrence of breast cancer in the ipsilateral breast: the NRG Oncology\/RTOG 1014 phase 2 clinical trial","volume":"6","author":"Arthur","year":"2020","journal-title":"JAMA Oncol"},{"issue":"10","key":"10.1016\/j.breast.2026.104895_bib9","doi-asserted-by":"crossref","first-page":"6440","DOI":"10.1245\/s10434-022-12197-6","article-title":"A systematic review and meta-analysis on the role of repeat breast-conserving surgery for the management of ipsilateral breast cancer recurrence","volume":"29","author":"Tollan","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.breast.2026.104895_bib10","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.ijrobp.2023.06.075","article-title":"Second conservative treatment for local recurrence breast cancer: a GEC-ESTRO oncological outcome and prognostic factor analysis","volume":"117","author":"Hannoun-Levi","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2026.104895_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(26)00177-4","article-title":"Local management of second ipsilateral breast cancer event after primary breast - conserving therapy: an international DELPHI consensus","author":"Hannoun-Levi","year":"2026","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.breast.2026.104895_bib12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4274\/ejbh.galenos.2022.2022-5-3","article-title":"Salvage mastectomy is not the treatment of choice for aggressive subtypes of ipsilateral breast cancer recurrence: a Single- institution retrospective study","volume":"18","author":"Gentile","year":"2022","journal-title":"Eur J Breast Health"},{"issue":"16","key":"10.1016\/j.breast.2026.104895_bib13","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1056\/NEJMoa052306","article-title":"Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer","volume":"353","author":"Piccart-Gebhart","year":"2005","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.breast.2026.104895_bib14","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1200\/JCO.20.01204","article-title":"Investigators. Adjuvant pertuzumab and trastuzumab in early HER2-Positive breast cancer in the APHINITY trial: 6 years' Follow-Up","volume":"39","author":"Piccart","year":"2021","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.breast.2026.104895_bib15","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"KEYNOTE-522 investigators. Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.breast.2026.104895_bib16","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1245\/s10434-026-19131-0","article-title":"Second ipsilateral breast cancer event: true recurrence, new primary, or true recurrence like? : breast cancer local recurrence","volume":"33","author":"Pujol","year":"2026","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.breast.2026.104895_bib17","doi-asserted-by":"crossref","first-page":"e818","DOI":"10.1634\/theoncologist.2018-0606","article-title":"Increased mortality with repeat lumpectomy alone after ipsilateral breast tumor recurrence","volume":"24","author":"Su","year":"2019","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.breast.2026.104895_bib18","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/S1470-2045(22)00447-8","article-title":"European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making","volume":"23","author":"Andratschke","year":"2022","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.breast.2026.104895_bib19","first-page":"630","article-title":"Reirradiation: Standards, challenges, and patient-focused strategies across tumor types","volume":"75","author":"Beddok","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.breast.2026.104895_bib20","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ijrobp.2025.05.077","article-title":"Salvage Therapy for Isolated Local-Regional Breast Cancer Recurrence","volume":"123","author":"Choi","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.breast.2026.104895_bib21","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.brachy.2022.07.004","article-title":"Partial breast irradiation: An updated consensus statement from the American brachytherapy society","volume":"21","author":"Anderson","year":"2022","journal-title":"Brachytherapy"},{"issue":"2","key":"10.1016\/j.breast.2026.104895_bib22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.prro.2023.11.001","article-title":"Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline","volume":"14","author":"Shaitelman","year":"2024","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.breast.2026.104895_bib23","volume":"59","author":"Polg\u00e1r","year":"2026","journal-title":"Clin Transl Radiat Oncol"},{"issue":"12","key":"10.1016\/j.breast.2026.104895_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2025.110484","article-title":"Local management of second breast cancer event after primary breast conserving therapy: The patient's perspective","volume":"51","author":"Hannoun-Levi","year":"2025","journal-title":"Eur J Surg Oncol"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977626002055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977626002055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:33:17Z","timestamp":1789612397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977626002055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":23,"alternative-id":["S0960977626002055"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2026.104895","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local treatment for HER2-positive or triple negative second ipsilateral breast cancer event: A propensity score-matched analysis of the GEC-ESTRO database","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2026.104895","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104895"}}